Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / SPONSORED ADR NE
-
Total 13F shares
-
242,159
-
Share change
-
-2,000
-
Total reported value
-
$293,358
-
Price per share
-
$1.21
-
Number of holders
-
3
-
Value change
-
-$2,420
-
Number of buys
-
1
-
Number of sells
-
1
Institutional Holders of XTL BIOPHARMACEUTICALS LTD - SPONSORED ADR NE (XTLB) as of Q4 2022
As of 31 Dec 2022,
XTL BIOPHARMACEUTICALS LTD - SPONSORED ADR NE (XTLB) was held by
3 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
242,159 shares.
The largest 3 holders included
Noked Israel Ltd, MORGAN STANLEY, and UBS Group AG.
This page lists
3
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.